Class 3 Recall - FINGOLIMOD CAP 0.5MG Active

Class 3 Recall - FINGOLIMOD CAP 0.5MG

Glenmark Pharmaceuticals Europe Ltd is recalling the above batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-glenmark-pharmaceuticals-europe-ltd-fingolimod-0-dot-5-mg-hard-capsules-el-24-a-slash-39?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=84383e4c-1c50-4c97-be85-13a3b91a3aa1&utm_content=immediately

Further Information For medical information enquiries please use the following options: by phone +44 8004 580 383 or email medical_information@glenmarkpharma.com

For medical information enquiries please email dl-drugsafety@strides.com and DL-GPV-Group@arcolab.com or telephone 01923 255580.

For stock control enquiries please email orders.uk@glenmarkpharma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.